Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fujimoto

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Oncology|August 12, 2010
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II studyHideyuki Akaza, Isao Ikemoto, Mikio Namiki, et al.
Surgical Case Reports|December 29, 2025
Metachronous Isolated Inguinal Lymph Node Metastasis at a Previous Hernia Repair Site following Potentially Curative Surgery for Transverse Colon Cancer: A Case ReportHiroyuki Fujimoto, Masatsune Shibutani, Yuki Seki, et al.
Respirology Case Reports|June 15, 2026
Intrapleural Gentian Violet Irrigation for Refractory Methicillin-Resistant <i>Staphylococcus aureus</i> Empyema: A Case SeriesYasoo Sugiura, Hiroyuki Fujimoto, Yoshihiko Morikawa, et al.
European Urology|January 20, 2016
A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate CancerKazuhiro Yoshimura, Takafumi Minami, Masahiro Nozawa, et al.
Case Reports in Oncology|August 7, 2018
Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder CancerSatoko Arai, Tomohiko Hara, Yoshiyuki Matsui, et al.
Annals of Nuclear Medicine|August 12, 2025
Feasibility of targeted alpha therapy for Alzheimer's disease using <sup>211</sup>At-labeled agent targeting amyloid-β aggregatesRikuto Kashiyama, Hiroyuki Watanabe, Takahiro Akasaka, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2011
Three-dimensional ex vivo imaging and analysis of intraportal islet transplantsHiroyuki Fujimoto, Kentaro Toyoda, Teru Okitsu, et al.
Scientific Reports|July 1, 2016
Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell CarcinomaKosuke Saito, Eri Arai, Keiko Maekawa, et al.
The Journal of Urology|November 6, 2012
Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomyTohru Nakagawa, Tomohiko Hara, Takashi Kawahara, et al.
International Cancer Conference Journal|March 25, 2024
Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancerTakahiro Kirisawa, Eijiro Nakamura, Tomoya Okuno, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Oncology|August 12, 2010
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II studyHideyuki Akaza, Isao Ikemoto, Mikio Namiki, et al.
Surgical Case Reports|December 29, 2025
Metachronous Isolated Inguinal Lymph Node Metastasis at a Previous Hernia Repair Site following Potentially Curative Surgery for Transverse Colon Cancer: A Case ReportHiroyuki Fujimoto, Masatsune Shibutani, Yuki Seki, et al.
Respirology Case Reports|June 15, 2026
Intrapleural Gentian Violet Irrigation for Refractory Methicillin-Resistant <i>Staphylococcus aureus</i> Empyema: A Case SeriesYasoo Sugiura, Hiroyuki Fujimoto, Yoshihiko Morikawa, et al.
European Urology|January 20, 2016
A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate CancerKazuhiro Yoshimura, Takafumi Minami, Masahiro Nozawa, et al.
Case Reports in Oncology|August 7, 2018
Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder CancerSatoko Arai, Tomohiko Hara, Yoshiyuki Matsui, et al.
Annals of Nuclear Medicine|August 12, 2025
Feasibility of targeted alpha therapy for Alzheimer's disease using <sup>211</sup>At-labeled agent targeting amyloid-β aggregatesRikuto Kashiyama, Hiroyuki Watanabe, Takahiro Akasaka, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2011
Three-dimensional ex vivo imaging and analysis of intraportal islet transplantsHiroyuki Fujimoto, Kentaro Toyoda, Teru Okitsu, et al.
Scientific Reports|July 1, 2016
Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell CarcinomaKosuke Saito, Eri Arai, Keiko Maekawa, et al.
The Journal of Urology|November 6, 2012
Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomyTohru Nakagawa, Tomohiko Hara, Takashi Kawahara, et al.
International Cancer Conference Journal|March 25, 2024
Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancerTakahiro Kirisawa, Eijiro Nakamura, Tomoya Okuno, et al.
Pageof 19